Description
Tesamorelin 10 mg | Pure Lab Peptides Supply
Tesamorelin 10 mg: Research Material
Buy Tesamorelin 10 mg from Pure Lab Peptides Supply. Each listing specifies lyophilized powder in one boxed 3 mL vial for laboratory research.
Tesamorelin is a modified analogue of growth hormone-releasing hormone (GHRH). Its reference structure contains 44 amino acids and an N-terminal hexenoyl group. Consequently, researchers can distinguish its structural characteristics from those of shorter GHRH-related peptides.
Product Overview
- Product name: Tesamorelin
- Labeled quantity: 10 mg
- Presentation: One boxed 3 mL vial
- Physical format: Lyophilized powder
- Compound class: Modified GHRH analogue
- Reference sequence length: 44 amino acids
- N-terminal modification: Added trans-3-hexenoyl group
- Product type: Single-compound listing
- Intended application: Laboratory research
- Documentation: Available product records and batch reports, where provided
The 10 mg label specifies the stated quantity of material, whereas 3 mL describes the vial’s capacity. Therefore, vial capacity does not indicate the amount of liquid supplied or establish a prepared concentration.
Choose the Material and Presentation
This listing describes single-compound Tesamorelin. It differs from Sermorelin and from the Tesamorelin + Ipamorelin blend, which combines two compounds.
Pure Lab Peptides Supply also lists Tesamorelin in 5 mg and 20 mg presentations. Compare the labeled quantity, product format, and available documentation to identify the appropriate listing for your laboratory records.
For combination products, check the stated composition before comparing quantities. The total amount of a blend includes its individual components, so it should not automatically be interpreted as the amount of Tesamorelin alone.
Tesamorelin Identity and Analytical Research
Researchers use analytical methods to investigate the identity and characteristics of GHRH-related peptides. For example, the study Qualitative Identification of Growth Hormone-Releasing Hormones in Human Plasma by Means of Immunoaffinity Purification and LC-HRMS/MS examined antibody-based capture followed by high-resolution tandem mass spectrometry.
The study distinguishes 44-amino-acid Tesamorelin from Sermorelin, a shorter 1–29 fragment of GHRH. Moreover, researchers observed differences in the peptides’ degradation behavior under the specific plasma-testing conditions.
These findings provide useful context for compound identification and the analysis of degradation products. However, plasma experiments do not establish the storage temperature, expiration date, or shelf life of the material supplied in this vial.
Product Records and Batch Reports
Review the available COA & Documents to locate product records and relevant batch reports.
When reviewing a certificate of analysis (COA), first match the report to the product and lot number. Then evaluate the identity, purity, and measured content results separately because each measurement addresses a different analytical question.
For instance, a purity percentage describes the result of a particular analytical method; it does not independently confirm the total amount in a vial. Likewise, a report for one lot does not automatically establish the results for another.
Additional Product Information
| Specification | Details |
|---|---|
| CAS number | 218949-48-5; verify against the exact chemical form |
| Reference molecular formula | C221H366N72O67S, as supplied; verify against authoritative product documentation |
| Reference molecular weight | 5,135.9 g/mol, as supplied; verify against the stated chemical form |
| Listed purity specification | ≥99%; consult the applicable batch report |
| Synthesis method | Solid-phase synthesis, as listed |
| Appearance | White lyophilized powder, as listed |
| Physical format | Lyophilized powder |
| Listed solubility | Water or 1% acetic acid; confirm using product-specific documentation |
| Listed storage | −20°C; follow verified product-specific instructions |
| Shipping conditions | Ambient-temperature shipping, as listed |
| Manufacturing claims | Confirm cGMP-related claims through applicable manufacturing and quality records |
| Safety documentation | Consult the applicable safety data sheet (SDS/MSDS) |
The listed molecular formula and molecular weight require verification against the exact chemical form, including any counterion. In addition, confirm that the stated CAS number and structural information correspond to the material described in the product documentation.
Similarly, the general purity specification of ≥99% does not replace the result reported for a particular batch. Check the original documentation before relying on specifications related to solubility, storage, shipping, or manufacturing.
Tesamorelin 10 mg Certificate of Analysis
The supplied product information identifies third-party laboratory documentation for a specific Tesamorelin 10 mg batch. The reported summary contains the following details:
- Lot number: 63747
- Report number: IF-824-QSA-TR006-2026-127-62
- Date tested: March 2, 2026
- Reported purity: 99.9%
- Labeled content: 10 mg
The reported 99.9% purity represents the stated batch-specific analytical result, while 10 mg identifies the labeled quantity. These figures describe different properties and should not be treated as interchangeable.
Before relying on the results, match the original report to lot 63747 and confirm the report number, test date, analytical method, and reported findings. If the original laboratory report differs from the summary, use the original report as the controlling source.
Packaging, Storage, and Handling
Tesamorelin 10 mg comes in lyophilized powder form in one boxed 3 mL vial. For appropriate laboratory recordkeeping, retain the product label and any available batch documentation together.
The supplied product information lists storage at −20°C. Nevertheless, confirm this requirement against current, product-specific documentation before applying it. Research on peptide behavior in plasma cannot independently establish the storage conditions or shelf life of the supplied material.
Order Tesamorelin 10 mg Research Material
Tesamorelin 10 mg offers a single-compound presentation for laboratories examining GHRH-related research materials. Before ordering, compare the labeled quantity, vial format, compound identity, and available batch records.
Visit Pure Lab Peptides Supply to review the product catalog and available documentation.
Research-use notice: This product is intended for laboratory research only. It is not presented as a medicine, dietary supplement, or product for human or veterinary use.

















